MyAverix Finance
SHG · Healthcare
Hubei Jumpcan Pharmaceutical Co Ltd (600566)
Drug Manufacturers - Specialty & Generic
Hubei Jumpcan Pharmaceutical Co Ltd (600566) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $23.61B, P/E ratio is 14.24, net margin is 26.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600566
Hubei Jumpcan Pharmaceutical Co Ltd (600566) — FAQ
What is Hubei Jumpcan Pharmaceutical Co Ltd's market cap?
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a reported market cap of $23.61B (data as of 2026-03-28).
What is 600566's P/E ratio?
The price-to-earnings (P/E) ratio for Hubei Jumpcan Pharmaceutical Co Ltd (600566) is 14.24 (data as of 2026-03-28).
Does Hubei Jumpcan Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hubei Jumpcan Pharmaceutical Co Ltd (600566). Check the MyAverix Finance app for the latest dividend data.
What sector is Hubei Jumpcan Pharmaceutical Co Ltd in?
Hubei Jumpcan Pharmaceutical Co Ltd (600566) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600566 listed on?
600566 is listed on SHG.
What is Hubei Jumpcan Pharmaceutical Co Ltd's net margin?
Hubei Jumpcan Pharmaceutical Co Ltd (600566) reports a net margin of 26.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.